TSS
QTTB icon

Two Sigma Securities’s Q32 Bio QTTB Stock Holding History

Two Sigma Securities’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,749
Closed -$27.2K – 2113
2025
Q3 		$27.2K Buy
+13,749
New +$26.4K ﹤0.01% 1080
2023
Q4 		– Sell
-559
Closed -$11.8K – 3700
2023
Q3 		$11.8K Sell
559
-42
-7% -$856 ﹤0.01% 2668
2023
Q2 		$9.58K Buy
+601
New +$10.8K ﹤0.01% 2603
2023
Q1 		– Sell
-711
Closed -$16.1K – 3399
2022
Q4 		$16.1K Buy
+711
New +$18.9K ﹤0.01% 2298

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Securities's QTTB Position: Q4 2025 in Review

Two Sigma Securities sold out of Q32 Bio (QTTB) in Q4 2025, closing a stake of 13,749 shares — an estimated $27.2K sold.

Two Sigma Securities first reported a position in QTTB in Q4 2022 and held it in 4 quarters. The position peaked at $27.2K in Q3 2025. 52 funds tracked by Wall St. Rank hold QTTB as of Q4 2025.

  • Two Sigma Securities reported no remaining Q32 Bio position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Securities sold 13,749 Q32 Bio shares in Q4 2025, an estimated $27.2K.
  • Two Sigma Securities first reported a position in Q32 Bio in Q4 2022 and held it in 4 quarters.
  • Two Sigma Securities's Q32 Bio position peaked at $27.2K in Q3 2025.
  • 52 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.